221 related articles for article (PubMed ID: 22100635)
1. Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis.
Poljak A; Comstedt P; Hanner M; Schüler W; Meinke A; Wizel B; Lundberg U
Vaccine; 2012 Jun; 30(29):4398-406. PubMed ID: 22100635
[TBL] [Abstract][Full Text] [Related]
2. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive acquired immunity influences transmission success of the Lyme disease pathogen, Borrelia afzelii.
Jacquet M; Durand J; Rais O; Voordouw MJ
Infect Genet Evol; 2015 Dec; 36():131-140. PubMed ID: 26384476
[TBL] [Abstract][Full Text] [Related]
4. Rapid outer-surface protein C DNA tattoo vaccination protects against Borrelia afzelii infection.
Wagemakers A; Mason LM; Oei A; de Wever B; van der Poll T; Bins AD; Hovius JW
Gene Ther; 2014 Dec; 21(12):1051-7. PubMed ID: 25273355
[TBL] [Abstract][Full Text] [Related]
5. Investigating BB0405 as a novel Borrelia afzelii vaccination candidate in Lyme borreliosis.
Klouwens MJ; Trentelman JJ; Ersoz JI; Nieves Marques Porto F; Sima R; Hajdusek O; Thakur M; Pal U; Hovius JW
Sci Rep; 2021 Feb; 11(1):4775. PubMed ID: 33637813
[TBL] [Abstract][Full Text] [Related]
6. Design and development of a novel vaccine for protection against Lyme borreliosis.
Comstedt P; Hanner M; Schüler W; Meinke A; Lundberg U
PLoS One; 2014; 9(11):e113294. PubMed ID: 25409015
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing the antigenic reactivity of Borrelia burgdorferi, the Lyme disease spirochete.
Schwan TG; Simpson WJ
Scand J Infect Dis Suppl; 1991; 77():94-101. PubMed ID: 1947819
[TBL] [Abstract][Full Text] [Related]
8. Arthritogenicity of Borrelia burgdorferi and Borrelia garinii: comparison of infection in mice.
Craig-Mylius KA; Lee M; Jones KL; Glickstein LJ
Am J Trop Med Hyg; 2009 Feb; 80(2):252-8. PubMed ID: 19190223
[TBL] [Abstract][Full Text] [Related]
9. Coinfection with Borrelia burgdorferi sensu stricto and Borrelia garinii alters the course of murine Lyme borreliosis.
Hovius JW; Li X; Ramamoorthi N; van Dam AP; Barthold SW; van der Poll T; Speelman P; Fikrig E
FEMS Immunol Med Microbiol; 2007 Mar; 49(2):224-34. PubMed ID: 17328756
[TBL] [Abstract][Full Text] [Related]
10. Cytokines in the serum and brain in mice infected with distinct species of Lyme disease Borrelia.
Isogai E; Isogai H; Kimura K; Hayashi S; Kubota T; Nishikawa T; Nakane A; Fujii N
Microb Pathog; 1996 Dec; 21(6):413-9. PubMed ID: 8971682
[TBL] [Abstract][Full Text] [Related]
11. A new approach to a Lyme disease vaccine.
Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ
Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of Lyme borreliosis with western blotting].
Hulínská D
Epidemiol Mikrobiol Imunol; 1997 Mar; 46(1):3-8. PubMed ID: 9162453
[TBL] [Abstract][Full Text] [Related]
14. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens.
Assous MV; Postic D; Paul G; Névot P; Baranton G
Eur J Clin Microbiol Infect Dis; 1993 Apr; 12(4):261-8. PubMed ID: 8513814
[TBL] [Abstract][Full Text] [Related]
15. Rapid typing of Borrelia burgdorferi sensu lato species in specimens from patients with different manifestations of Lyme borreliosis.
Lünemann JD; Zarmas S; Priem S; Franz J; Zschenderlein R; Aberer E; Klein R; Schouls L; Burmester GR; Krause A
J Clin Microbiol; 2001 Mar; 39(3):1130-3. PubMed ID: 11230440
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of antigenic variation in Lyme borreliosis and relapsing fever: a comparative analysis.
Barbour AG
Scand J Infect Dis Suppl; 1991; 77():88-93. PubMed ID: 1947817
[TBL] [Abstract][Full Text] [Related]
17. A recombinant vaccine for Lyme disease.
Wallich R; Kramer MD; Simon MM
Behring Inst Mitt; 1994 Dec; (95):106-8. PubMed ID: 7755503
[TBL] [Abstract][Full Text] [Related]
18. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice.
Keane-Myers A; Nickell SP
J Immunol; 1995 Feb; 154(4):1770-6. PubMed ID: 7836761
[TBL] [Abstract][Full Text] [Related]
19. Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.
Volkman DJ; Luft BJ; Gorevic PD; Schultz J; Padovano L
J Immunol; 1991 May; 146(9):3177-82. PubMed ID: 2016542
[TBL] [Abstract][Full Text] [Related]
20. T helper cell priming of mice to Borrelia burgdorferi OspA leads to induction of protective antibodies following experimental but not tick-borne infection.
Zhong W; Gern L; Kramer M; Wallich R; Simon MM
Eur J Immunol; 1997 Nov; 27(11):2942-7. PubMed ID: 9394822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
